Discover Great Companies Discover Great Clients
Popularity  5.6万   |   Followers  29   |   Likes  13   |   Feedback  36 Claim this company
No.60 Qingdao City Popularity Ranking No.3 Jiaozhou City No.204 Shandong P No.1 Food Additives No.1 Lin Chuang Yi Xue No.3 Health Products No.3 Health No.3 Gong Cheng Yan Jiu Center No.3 Fine Chemicals No.3 Nutrition Food No.3 Health Products No.5 Pharmaceutical No.6 Pharmaceutical Industrial No.6 Zhi Yao / Yao Industries Wei Sheng Tai 省部级科技进步奖 科技进步奖 国家重点新产品 博士后工作站 高新技术企业 国家知识产权示范企业
More

Company Overview

  • Nature: Private Enterprise Size: 100-499 employees Founded: 23年
  • Industry: Pharmaceutical/Biotechnology 、 Wholesale/Retail
  • Full name: Qingdao Donghai Pharmaceutical Co., Ltd.。

Development Stage

  • Ranking: Ranked #60 in Qingdao City by popularity Ranked #1 in Qingdao Food Additives Company by popularity Ranked #1 in Qingdao Lin Chuang Yi Xue Company by popularity Ranked #3 in Qingdao Health Products Company by popularity Ranked #3 in Qingdao Health Company by popularity
  • Honors: 省部级科技进步奖 科技进步奖 According to algorithm
  • Salary: 53% of positions earn 6-10K, In 2026 vs last yeardecreased by 9%.。Master's salary: ¥11.8K, Doctorate salary: ¥29.3K.
  • R&D: "Computer/Network/Technology" demand: 25.1%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 7%, "Scientific Research": 7%。
  • Recruiting: In 2026 vs 2025grew by 1%. Demand for highly educated talent: Master's: 10, Doctorate: 4.
  • Requirement: Education: 本科 leads with 50.3%. Experience: 不限 leads with 51.9%.
  • Region: Distributed across 1 regions, 青岛: 100%.

About the Company

Qingdao Donghai Pharmaceutical Co., Ltd. is located in Qingdao West Coast New Area. It is a high-tech enterprise specializing in the research, development, and production of innovative microecological drugs, and owns China's first National-Local Joint Engineering Research Center for Medical Microecological Products. It is also the first national demonstration project base for microecological drug industrialization supported by the National Development and Reform Commission, a national intellectual property advantage enterprise, and has a post-doctoral research station. Over the past two decades, Qingdao Donghai Pharmaceutical has been dedicated to the research, development, and production of human microecological drugs (products), and has successively won support from 4 national key new products, 4 national high-tech products, and 2 national Torch Program projects. To date, it has applied for over 70 invention patents for new microecological drugs, with 21 authorized, including 2 US invention patents for new microecological drugs. It has led and completed 5 microecological drug projects under the National High-Tech R&D Program (863 Program), developed one-third of China's total microecological drugs, and fully industrialized all of them. It has also taken the lead in formulating national standards for 6 microecological drugs. Microecological drugs launched and sold on the market, such as Atining and Bao Le'an, have relieved millions of patients, including Academician Yuan Longping, the father of hybrid rice, from the pain of irritable bowel syndrome and chronic diarrhea triggered by cold exposure, alcohol consumption, or spicy hotpot, earning high recognition from Academician Yuan Longping and numerous patients and experts. The company has also won the First Prize of Qingdao Technical Invention Award and the First Prize of Shandong Provincial Science and Technology Progress Award. In 2019, Donghai Pharmaceutical obtained 18 million yuan in funding support from Shandong Province's major new drug creation and development project. It is currently conducting research and development on multiple Class 1.1 new drugs, including anti-tumor drugs, and has already received default permission for clinical research on a Class 1.1 new drug. It is a leader in the field of microecological medicine in China.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (57 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 11%
  • 2024: Down 35%
  • 2023: Up 30%
  • 2022: Up 66%
Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Campus Recruitment & Advanced Degree Talent Demand
Graduates 8 Master's 10 Doctorate 4
Note: How fast is hiring at Qingdao Donghai Pharmaceutical Co., Ltd. growing? 2026: 160 openings (up 1%), 2025: 158 openings (up 11%), 2024: 142 openings (down 35%), 2023: 219 openings (up 30%), 2022: 168 openings (up 66%), 2021: 101 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 35%
  • 2024: Down 23%
  • 2023: Up 22%
  • 2022: Up 80%
Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Qingdao Donghai Pharmaceutical Co., Ltd. growing? Master's recruitment over the years: 2025: 11 openings (down 35%), 2024: 17 openings (down 23%), 2023: 22 openings (up 22%), 2022: 18 openings (up 80%), 2021: 10 openings. Qingdao Donghai Pharmaceutical Co., Ltd. master talent ranking in Qingdao: #35, Qingdao Donghai Pharmaceutical Co., Ltd. master salary mostly around 8-15K.

Doctoral Degree Job Demand Analysis

(More)
+600%
Growth Rate
2026 vs 2025
  • 2025: Down 67%
  • 2024: Down 50%
  • 2023: Down 25%
  • 2022: Up 300%
Doctoral Hiring by Year: 2026 — 6 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
No.53
Doctoral Demand Ranking in Qingdao City 򀀩
¥20-50K
Doctoral Salary 򀀩
How fast is doctoral hiring at Qingdao Donghai Pharmaceutical Co., Ltd. growing? Doctorate recruitment over the years: 2026: 7 openings (up 600%), 2025: 1 openings (down 67%), 2024: 3 openings (down 50%), 2023: 6 openings (down 25%), 2022: 8 openings (up 300%), 2021: 2 openings. Qingdao Donghai Pharmaceutical Co., Ltd. doctorate talent ranking in Qingdao: #53, Qingdao Donghai Pharmaceutical Co., Ltd. doctorate salary mostly around 20-50K.

R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Qingdao Donghai Pharmaceutical Co., Ltd.? Based on an analysis of 's job postings over the past year, "Computer/Network/Technology" demand: 25.1%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 7%, "Scientific Research": 7%, "Art/Design/Creative": 7%, "Other (R&D and Technical)": 6.4%, "Medical & Health/Beauty & Healthcare": 6.4%. For reference only.

— What Are the Salaries Like? (187 records)

Manage
salary range: 3K - 50K, 53% of roles pay ¥6-10K
Note: salary statistics are based on 187 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Qingdao Donghai Pharmaceutical Co., Ltd.?53% of positions earn 6-10K, Fresh graduate salary: ¥11.0K。Qingdao salary ranking top 35,客户服务类 average salary ¥10.5K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at Qingdao Donghai Pharmaceutical Co., Ltd.? We provide: Operations, 后备干部, Copywriter, New Media Specialist, Researcher, Director, Information, Live Streamer, Finance Specialist, Sales, Live Streamer, HR Specialist, Health Consultant, Promotion Specialist, Legal Counsel, QA, BP, Product Manager, Accountant, 健康顾问. Click to view detailed salary analysis by job.

Job Category

  • 客户服务类
    28% of total 28%
  • 计算机/网络/技术类
    25.4% of total 25.4%
  • 市场/公关/媒介类
    20.1% of total 20.1%
  • 文体/影视/写作/媒体类
    16.4% of total 16.4%

Education

  • 本科
    50.3% of total 50.3%
  • 大专
    22.2% of total 22.2%
  • 硕士
    12.7% of total 12.7%
  • 不限
    9.5% of total 9.5%

Experience

  • 不限
    51.9% of total 51.9%
  • 1-3年
    28.6% of total 28.6%
  • 5-10年
    10.1% of total 10.1%
  • 3-5年
    6.9% of total 6.9%
View Detailed Analysis

What does Qingdao Donghai Pharmaceutical Co., Ltd. require? Who is Qingdao Donghai Pharmaceutical Co., Ltd. hiring? recruitment: 客户服务类占比最多占28%,其次是计算机/网络/技术类占25.4%. What education can get in at ? 本科占比最多占50.3%,其次是大专占22.2%. High education required at ? 硕士占12.7%,博士占3.7%. Work experience required at ? 不限占比最多占51.9%,其次是1-3年占28.6%. Where are the job locations at ? 青岛占比最多占100%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 6,000万(元)
Legal Representative: 崔云龙
Date Established:
Credit Code: 91370211750444874X
Registered Address: 青岛市黄岛区胶州湾西路1377号

Partners & Suppliers

青岛东海药业与上海医药签署年度经销协议,产品纳入其医药流通网络 Source
合作客户 医药商业/分销
青岛东海药业与国药控股签订战略合作协议,通过其全国分销网络销售微生态制剂产品 Source
合作客户 医药商业/分销
提供海洋寡糖原料 Source
供应商 医药客户-特医食品
青岛东海药业在京东大药房上架产品,由京东物流配送 Source
合作客户 线上零售平台
青岛东海药业在阿里健康平台开设官方旗舰店,销售阿泰宁等益生菌产品 Source
合作客户 线上零售平台

People who follow this company also follow

Competitors (Similar Companies)

“以南极磷虾为主的海洋医药与生物制品的综合开发与利用”
海藻 生物制品 海洋工程 生产
“Full industry chain of integrated circuits covering chip R&D, design, ”
合金钢 高温合金 型钢 合金材料
“贝克曼沃玛作为全球主要风能发电设备制造企业的A级供应商”
“Carrying expectations, strict management, perseverance, and pursuit of”
医药 制药/药业 中成药 化学制药
“"Do it well before you say it" is Hailir's eternal commitment!”
压铸 铝制品 数控/CNC 铸造
DHA 功能食品 医药原料 动物油
大健康 药品零售 医药集团 贸易
农机链 摩托车链 摩托车 汽车零部件/配件
“主营业务为酶制剂、微生态、动物保健品的研发、生产和销售”
轨道交通装备 生产 轨道交通技术 国有资本
智慧农业 通信芯片 卫星通信 卫星互联网

Discover Great Companies, Discover Great Clients

青岛公司名录 青岛“Jiaozhou City”公司名录 青岛“工程研究中心”公司名录 青岛“食品添加剂”公司名录 青岛“精细化工”公司名录 青岛“营养食品”公司名录 青岛“健康产品”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates